Founded in 1986 in the UK, Shire embarked on its mission to “enable people with life-altering conditions to lead better lives”. With a deep understanding of patients’ needs, Shire develops and provides healthcare in the areas of behavioural health and gastro-intestinal conditions, rare diseases, and regenerative medicine. Shire is one of the fastest growing pharmaceutical companies in the world, with $5 billion in annual revenues, and more than 5000 employees in 50 countries around the world.
Shire continues to experience rapid growth, primarily through acquisitions. The company required a business management solution that is fast to implement, easy to learn and use, offers broad flexibility, and can scale to accommodate growth.
Shire uses Sage X3 as the backbone of its financial services for its small- to medium-sized European subsidiaries, supporting operations across nine different countries, with plans to roll out Sage X3 out across additional sites in the near future.
New acquisitions are up and running quickly and cost effectively, on a common platform with a consistent chart of accounts, meaning fewer personnel are required, and controllers can focus on their mission. Daily tasks are simplified and streamlined, freeing staff time for strategic initiatives. The common platform facilitates personnel sharing across the enterprise. Reports can be generated centrally in a consistent format. Software maintenance costs are lower.